MedPharm UK – Guildford
MedPharm – Guildford Facility | Formulation Development in Surrey, UK
Formulation Development Facility
Unit 2, Surrey Research Park
Guildford, Surrey GU2 7AB, United Kingdom
Tel: +44 (0)1483 457 580
Overview
MedPharm’s Guildford facility, located in the Surrey Research Park in Guildford, Surrey, UK, is a premier center for formulation development and pharmaceutical innovation. Purpose-built for the design and development of liquid and semi-solid drug products, this site is focused on translating novel therapeutic concepts into viable clinical and commercial drug products.
Our laboratories are tailored to deliver full-service formulation strategy, analytical development, product characterization, and stability testing, with a proven track record of advancing complex formulations from bench to batch.
We offer end-to-end CDMO services from early-stage formulation through clinical trial material (CTM) production and beyond, specializing in:
- Semi-solid and liquid pharmaceutical formulations
- Stability studies and clinical trial material manufacturing
- Small molecule drug products
- Biologic formulations
MedPharm Guildford is where innovative formulation meets regulatory excellence — helping you turn novel ideas into real-world therapies.
Facilities
Our state-of-the-art laboratories in Guildford have been exclusively designed to support the unique needs of liquid and semi-solid product development. Specialized labs at this site include:
- Formulation Development Laboratories for prototype design and optimization
- Process Development Labs for scalable, GMP-ready processes
- Formulation Characterization Suites for rheology, texture, and delivery profiling
- Analytical Laboratories supporting method development and validation
- On-site Quality Control (QC) Labs for batch release, raw material testing, and stability monitoring
This specialized infrastructure allows MedPharm to ensure product robustness and regulatory readiness from the earliest development stages.
Specialized Capabilities
Our Guildford location delivers a full range of technical capabilities to ensure development continuity and speed-to-clinic:
- Formulation strategy and selection tailored to your molecule’s properties and delivery goals
- Rapid prototyping and proof-of-concept evaluations
- Stability studies under ICH conditions
- Clinical trial material (CTM) manufacturing and packaging for Phase I–III studies
- Analytical method development and validation aligned with regulatory expectations
- Process development and scale-up support for global tech transfer
With expertise in semi-solids, liquids, biologics, and small molecules, MedPharm UK enables your team to reduce risk, accelerate timelines, and meet critical development milestones.
Quality and Compliance
MedPharm maintains a strong commitment to quality assurance and regulatory compliance at every stage of development. Our UK operations adhere to MHRA and EU GMP standards, with robust QA and QC systems and QP oversight in EU and UK.
We ensure that your product development journey meets global expectations for quality, safety, and performance.
